Choreo LLC Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Choreo LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,604 shares of the medical equipment provider's stock after selling 770 shares during the period. Choreo LLC's holdings in Intuitive Surgical were worth $5,747,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of ISRG. Norges Bank bought a new position in shares of Intuitive Surgical during the fourth quarter valued at about $2,401,493,000. GAMMA Investing LLC lifted its position in shares of Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. Capital Research Global Investors lifted its position in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. Finally, GQG Partners LLC lifted its position in shares of Intuitive Surgical by 42.5% during the fourth quarter. GQG Partners LLC now owns 1,145,300 shares of the medical equipment provider's stock valued at $597,801,000 after purchasing an additional 341,812 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.5%

Shares of ISRG stock traded up $7.25 during trading hours on Friday, reaching $495.86. The stock had a trading volume of 1,870,941 shares, compared to its average volume of 1,842,693. The stock's fifty day simple moving average is $529.86 and its 200 day simple moving average is $535.07. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market capitalization of $177.76 billion, a PE ratio of 69.16, a PEG ratio of 5.53 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the previous year, the company earned $1.78 EPS. The business's quarterly revenue was up 21.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,798 shares of company stock worth $3,955,331 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ISRG shares. Piper Sandler restated an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday. Royal Bank Of Canada increased their price target on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a research report on Wednesday. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday. BTIG Research increased their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Robert W. Baird reduced their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $592.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.